AnalystsMichael OkunewitchMichael Okunewitch's Stock Forecasts
AnalystsMichael Okunewitch
Analyst Ranking
Bottom 6%
#4295 out of 4563 analysts
Average Return
-27.25%
Win Rate
14%2 out of 14
Risk vs Reward
Poor
Good
Michael Okunewitch Analyst Color
Get additional color on Michael Okunewitch's coverage of popular stocks
Michael Okunewitch's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Lexaria Bioscience CorpLEXX | 2 | Strong Buy | $12.00 | +445.45% | Maintains | 2 months ago |
Dmk Pharmaceuticals CorpDMKPQ | 1 | Strong Buy | $1.50 | +546.55% | Initiates Coverage On | 5 months ago |
Acrivon Therapeutics IncACRV | 1 | Strong Buy | $24.00 | +152.63% | Initiates Coverage On | 7 months ago |
Anebulo Pharmaceuticals IncANEB | 1 | Strong Buy | $6.00 | +115.05% | Initiates Coverage On | 7 months ago |
Alzamend Neuro IncALZN | 1 | Strong Buy | $22.50 | N/A | Initiates Coverage On | a year ago |
Kiora Pharmaceuticals IncKPRX | 2 | Strong Buy | $12.00 | N/A | Upgrades | a year ago |
Mediwound LtdMDWD | 1 | Strong Buy | $25.00 | N/A | Initiates Coverage On | a year ago |
Biorestorative Therapies IncBRTX | 1 | Strong Buy | $6.00 | N/A | Initiates Coverage On | 2 years ago |
Hcw Biologics IncHCWB | 1 | Strong Buy | $4.00 | N/A | Initiates Coverage On | 2 years ago |
Longeveron IncLGVN | 1 | Strong Buy | $140.00 | N/A | Initiates Coverage On | 2 years ago |
Seqll IncSEQL | 1 | Strong Buy | $120.00 | N/A | Initiates Coverage On | 2 years ago |
Atai Life Sciences NvATAI | 1 | Strong Buy | $25.00 | N/A | Initiates Coverage On | 2 years ago |
Citius Pharmaceuticals IncCTXR | 1 | Strong Buy | $4.00 | N/A | Initiates Coverage On | 2 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.